Elder Pharmaceuticals is currently trading at Rs. 347.00, up by 0.90 points or 0.26% from its previous closing of Rs. 346.10 on the BSE.
The scrip opened at Rs. 352.20 and has touched a high and low of Rs. 352.20 and Rs. 347.00 respectively. So far 17,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 435.00 on 29-Jul-2011 and a 52 week low of Rs. 328.00 on 20-Dec-2011.
Last one week high and low of the scrip stood at Rs. 356.00 and Rs. 344.00 respectively. The current market cap of the company is Rs. 712.00 crore.
The promoters holding in the company stood at 39.60% while Institutions and Non-Institutions held 25.13% and 35.27% respectively.
Elder Pharmaceuticals through its Dubai’s wholly owned subsidiary has increased its stake in Elder Biomeda AD, Bulgaria on February 07, 2012. The company has increased its stake from 92.20% to 100%.
Elder Pharmaceuticals (EPL) has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.
